Table 1.
Characteristics of eligible patients with and without discontinuation of follow‐up visits for diabetes
| Variable | Category | No discontinuation | Discontinuation | P‐value |
|---|---|---|---|---|
| 5,194 | 1,314 | |||
| Age (years) | 20–39 | 261 (5.0%) | 87 (6.6%) | 0.006 |
| 40–49 | 1,848 (35.6%) | 412 (31.4%) | ||
| 50–59 | 2,103 (40.5%) | 569 (43.3%) | ||
| ≥60 | 982 (18.9%) | 246 (18.7%) | ||
| Sex | Male | 4,046 (77.9%) | 1,117 (85.0%) | <0.001 |
| Body mass index (kg/m2) | ≤18.49 | 69 (1.3%) | 10 (0.8%) | 0.410 |
| 18.50–24.99 | 1,830 (35.2%) | 470 (35.8%) | ||
| 25.00–29.99 | 2,129 (41.0%) | 538 (40.9%) | ||
| ≥30.00 | 1,165 (22.4%) | 292 (22.2%) | ||
| Missing | 1 (<0.1%) | 4 (0.3%) | ||
| Waist circumference (cm) | M: <85 cm, F: <90 cm | 1,544 (29.7%) | 366 (27.9%) | 0.200 |
| M: ≥85 cm, F: ≥90 cm | 3,497 (67.3%) | 905 (68.9%) | ||
| Missing | 153 (2.9%) | 43 (3.3%) | ||
| Fasting blood glucose (mg/dL) | 126–199 | 3,771 (72.6%) | 1,118 (85.1%) | <0.001 |
| ≥200 | 1,423 (27.4%) | 196 (14.9%) | ||
| HbA1c, % (mmol/mol) | 6.5–6.9 (48–52) | 1,214 (23.4%) | 557 (42.4%) | <0.001 |
| 7.0–7.9 (53–63) | 1,557 (30.0%) | 419 (31.9%) | ||
| 8.0–8.9 (64–74) | 710 (13.7%) | 119 (9.1%) | ||
| ≥9.0 (≥75) | 1,713 (33.0%) | 219 (16.7%) | ||
| Blood pressure | Normal | 3,349 (64.5%) | 867 (66.0%) | 0.080 |
| Grade 1 hypertension | 1,228 (23.6%) | 319 (24.3%) | ||
| Grade 2 hypertension | 451 (8.7%) | 97 (7.4%) | ||
| Grade 3 hypertension | 162 (3.1%) | 27 (2.1%) | ||
| Missing | 4 (0.1%) | 4 (0.3%) | ||
| Triglycerides (mg/dL) | <150 | 2,587 (49.8%) | 688 (52.4%) | 0.110 |
| 150–299 | 1,855 (35.7%) | 458 (34.9%) | ||
| ≥300 | 736 (14.2%) | 161 (12.3%) | ||
| Missing | 16 (0.3%) | 7 (0.5%) | ||
| LDL cholesterol (mg/dL) | <120 | 1,428 (27.5%) | 374 (28.5%) | 0.470 |
| 120–139 | 1,158 (22.3%) | 306 (23.3%) | ||
| ≥140 | 2,531 (48.7%) | 617 (47.0%) | ||
| Missing | 77 (1.5%) | 17 (1.3%) | ||
| HDL cholesterol (mg/dL) | <40 | 819 (15.8%) | 194 (14.8%) | 0.370 |
| ≥40 | 4,371 (84.2%) | 1,119 (85.2%) | ||
| Missing | 4 (0.1%) | 1 (0.1%) | ||
| Urinary protein dipstick test | − or ± | 4,388 (84.5%) | 1,151 (87.6%) | <0.001 |
| ≥+ | 713 (13.7%) | 132 (10.0%) | ||
| Missing | 93 (1.8%) | 31 (2.4%) | ||
| Antidyslipidemia prescription | + | 486 (9.4%) | 81 (6.2%) | <0.001 |
| Antihypertensive prescription | + | 975 (18.8%) | 159 (12.1%) | <0.001 |
| Insured person | Identical person | 4,034 (77.7%) | 1,116 (84.9%) | <0.001 |
| Dependent | 1,160 (22.3%) | 198 (15.1%) | ||
| Frequency of physician visits in previous year (months/year) | 0 | 1,074 (20.7%) | 304 (23.1%) | <0.001 |
| 1–4 | 1,825 (35.1%) | 522 (39.7%) | ||
| 5–12 | 2,295 (44.2%) | 488 (37.1%) | ||
| Frequency of alcohol intake | Rarely | 1,807 (34.8%) | 402 (30.6%) | <0.001 |
| Occasionally | 1,504 (29.0%) | 379 (28.8%) | ||
| Regularly | 1,096 (21.1%) | 344 (26.2%) | ||
| Missing | 787 (15.2%) | 189 (14.4%) | ||
| Smoking | – | 3,230 (62.2%) | 757 (57.6%) | 0.003 |
| + | 1,615 (31.1%) | 461 (35.1%) | ||
| Missing | 349 (6.7%) | 96 (7.3%) | ||
| Stage in change model for lifestyle modifications | Precontemplation | 620 (11.9%) | 183 (13.9%) | 0.050 |
| Contemplation | 1,488 (28.6%) | 378 (28.8%) | ||
| Determination | 865 (16.7%) | 244 (18.6%) | ||
| Action | 459 (8.8%) | 99 (7.5%) | ||
| Maintenance | 754 (14.5%) | 169 (12.9%) | ||
| Missing | 1,008 (19.4%) | 241 (18.3%) | ||
| Willingness to receive health instruction from public health nurses | – | 2,386 (45.9%) | 648 (49.3%) | 0.480 |
| + | 1,374 (26.5%) | 354 (26.9%) | ||
| Missing | 1,434 (27.6%) | 312 (23.7%) | ||
| Urinary protein/albumin quantitative test performed in first month | + | 802 (15.4%) | 115 (8.8%) | <0.001 |
| Ophthalmological examination performed in first month | + | 944 (18.2%) | 143 (10.9%) | <0.001 |
| Nutritional guidance performed in first month | + | 1,083 (20.9%) | 180 (13.7%) | <0.001 |
| Total cost in first month ($US) | ≤149 | 1,327 (25.5%) | 549 (41.8%) | <0.001 |
| 150–299 | 1,930 (37.2%) | 415 (31.6%) | ||
| ≥300 | 1,937 (37.3%) | 350 (26.6%) | ||
| Main visited medical facility (clinic or hospital) | Clinic | 3,382 (65.1%) | 866 (65.9%) | 0.590 |
| Hospital | 1,812 (34.9%) | 448 (34.1%) | ||
| Antidiabetic prescription in first month | + | 2,657 (51.2%) | 308 (23.4%) | <0.001 |
| HbA1c in previous year, % (mmol/L) | ≤6.4 (≤47) | 765 (14.7%) | 264 (20.1%) | 0.001 |
| ≥6.5 (≥48) | 1,136 (21.9%) | 288 (21.9%) | ||
| Missing | 3,293 (63.4%) | 762 (58.0%) | ||
| Fasting blood glucose in previous year (mg/dL) | ≤125 | 1,072 (20.6%) | 340 (25.9%) | 0.002 |
| ≥126 | 840 (16.2%) | 195 (14.8%) | ||
| Missing | 3,282 (63.2%) | 779 (59.3%) |
F, female; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; M, male.